诱导治疗对肾移植后循环T滤泡辅助细胞及供者特异性抗体形成的影响
该前瞻性研究监测肾移植受者诱导治疗后循环T滤泡辅助细胞(cTFH)的变化,比较T细胞清除型(兔抗胸腺细胞球蛋白,n=54)与非清除型(巴利昔单抗,n=20)诱导方案,并设健康对照(n=13),共307份血样。研究发现兔抗胸腺细胞球蛋白显著清除cTFH并促使其向活化表型偏移;无论诱导方案,移植后产生供者特异性抗体(DSA)者移植前存在供者反应性记忆IL-21+ cTFH,且DSA发生时cTFH比例升高、TREG比例降低。
要点
- 兔抗胸腺细胞球蛋白诱导显著清除cTFH并诱导其向Th1极化、效应记忆及PD-1int/hi活化表型偏移。
- 移植前存在供者反应性记忆IL-21+ cTFH与移植后DSA形成相关。
- DSA发生时cTFH比例升高、TREG比例降低,cTFH:TREG比值升高。
核心结论
- 诱导治疗可显著塑造肾移植后cTFH细胞表型,监测cTFH可能有助于识别移植后易产生DSA的患者。
研究设计与样本
- 前瞻性监测肾移植受者从移植前至移植后1年的cTFH细胞,比较兔抗胸腺细胞球蛋白(n=54)与巴利昔单抗(n=20)诱导方案,并设健康对照(n=13),共307份血样。
主要发现
- 移植前患者静息及中枢记忆cTFH水平与健康对照相当,极化状态相似。
- 兔抗胸腺细胞球蛋白诱导显著清除cTFH,触发淋巴细胞减少诱导的增殖,使cTFH向Th1极化增加、效应记忆表型及PD-1int/hi表达升高,呈活化表型;巴利昔单抗无此效应。
- 无论诱导方案,移植后发生DSA者移植前存在供者反应性记忆IL-21+ cTFH,且移植后cTFH百分比更高、TREG百分比更低,DSA发生时cTFH:TREG比值升高。
临床怎么用
- 移植前后监测cTFH细胞(尤其供者反应性记忆IL-21+ cTFH及cTFH:TREG比值)可能帮助识别DSA高风险患者。
- 选择诱导方案时需考虑其对cTFH表型的影响,兔抗胸腺细胞球蛋白诱导后cTFH呈活化表型偏移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The cellular events that contribute to generation of donor-specific anti-HLA antibodies (DSA) post-kidney transplantation (KTx) are not well understood. Characterization of such mechanisms could allow tailoring of immunosuppression to benefit sensitized patients. METHODS: We prospectively monitored circulating T follicular helper (cTFH) cells in KTx recipients who received T-cell depleting (thymoglobulin, n = 54) or T-cell nondepleting (basiliximab, n = 20) induction therapy from pre-KTx to 1 year post-KTx and assessed their phenotypic changes due to induction and DSA occurrence, in addition to healthy controls (n = 13), for a total of 307 blood samples. RESULTS: Before KTx, patients displayed comparable levels of resting, central memory cTFH cells with similar polarization to those of healthy controls. Unlike basiliximab induction, thymoglobulin induction significantly depleted cTFH cells, triggered lymphopenia-induced proliferation that skewed cTFH cells toward increased Th1 polarization, effector memory, and elevated programmed cell death protein 1 (PD-1)int/hi expression, resembling activated phenotypes. Regardless of induction, patients who developed DSA post-KTx, harbored pre-KTx donor-reactive memory interleukin (IL)-21+ cTFH cells and showed higher % cTFH and lower % of T regulatory (TREG) cells post-KTx resulting in elevated cTFH:TREG ratio at DSA occurrence. CONCLUSION: Induction therapy distinctly shapes cTFH cell phenotype post-KTx. Monitoring cTFH cells before and after KTx may help detect those patients prone to DSA generation post-KTx.
引用
- Macedo C, Hadi K, Walters J, et al. Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant. Kidney Int Rep. 2018. PMID: 30899873. doi:10.1016/j.ekir.2018.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。